Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Paganini Biopharma Inc.
DescriptionHuman mAb against epithelial membrane protein 2 (EMP2)
Molecular Target Epithelial membrane protein 2 (EMP2)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationBreast cancer
Indication DetailsTreat triple negative breast cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today